Topical budesonide for treating giant rectal pseudopolyposis

Anticancer Research

Volumn 25, Issue 4, 2005, Pages 2961-2964

  Pilichos, Charalampos ^a,b   Preza, Athena ^a   Demonakou, Maria ^a   Kapatsoris, Dimitrios ^a   Bouras, Constantinos ^a  

^a SISMANOGLIO HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Budesonide; Hepatitis; Inflammatory polyps; Pseudopolyps; Ulcerative colitis

Indexed keywords

AMINOTRANSFERASE; BUDESONIDE; ENEMA; MESALAZINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLON MUCOSA; COMORBIDITY; ENDOSCOPY; ENTERITIS; HEALING; HEPATITIS C; HISTOLOGY; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL; RECTUM POLYP; ULCERATIVE COLITIS;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL POLYPS; MALE; MIDDLE AGED; RECTAL DISEASES;

EID: 22944458863     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Itzkowitz SH: Colonic polyps and polyposis syndromes. In: Gastrointestinal and Liver Disease (7th edition). Feldman M, Friedman LS and Sleisenger MH (eds.). Saunders, Philadelphia, 2002.
2. Hurlstone DP: Large-bowel obstruction secondary to localized rectal giant pseudopolyposis complicating ulcerative colitis: first reported case. Endoscopy 34(12): 1025, 2002.
3. Atten MJ, Attar BM, Mahkri MA, Del Pino A and Orsay CP: Giant pseudopolyps presenting as colocolic intussusception in Crohn's colitis. Am J Gastroenterol 93(9): 1591-1592, 1998.
4. Fitterer JD, Cromwell LG and Sims JE: Colonic obstruction by giant pseudopolyposis. Gastroenterology 72(1): 153-156, 1977.
5. Morris SJ, Greenwald RA and Tedesco FJ: Acute ulcerative colitis mimicking an obstructing carcinoma of the colon. Am J Gastroenterol 70(2): 194-196, 1978.
6. Maldonado TS, Firoozi B, Stone D and Hiotis K: Colocolonic intussusception of a giant pseudopolyp in a patient with ulcerative colitis: a case report and review of the literature. Inflamm Bowel Dis 10(1): 41-44, 2004.
7. Ambroze WL and Forde KA: Giant pseudopolyposis causing antegrade colonic obstruction. Int Surg 74(1): 40-42, 1989.
8. Marshall JK and Irvine EJ: Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther 9(3): 293-300, 1995.
9. Hanauer SB: Inflammatory bowel disease. N Engl J Med 334(13): 841-848, 1996.
10. Lemann M, Gornet JM, Allez M and Nachury M: Pour un usage raisonne des corticoïdes dans les maladies inflammatoires chroniques de l'intestin. Hépato-Gastro 11: 189-195, 2004.
11. Liaw YF: Hepatitis viruses under immunosuppressive agents. J Gastroenterol Hepatol 13(1): 14-20, 1998.
12. Monteleone G, Pender SL and Alstead E: Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 48(4): 584, 2001.
13. Mavrogiannis C, Papanikolaou IS, Elefsiniotis IS, Psilopoulos DI, Karameris A and Karvountzis G: Ulcerative colitis associated with interferon treatment for chronic hepatitis C. J Hepatol 34: 964-965, 2001.
14. Biancone L, Del Vecchio Blanco G and Pallone F: Immunomodulatory drugs in Crohn's disease patients with hepatitis B or C virus infection. Gastroenterology 122(2): 593-594, 2002.
15. Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, Hawley S, Barber J, Condreay L and Gray DF: Efficacy of lamivudine in patients with hepatitis B and antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group. Hepatology 29(3): 889-896, 1999.